BioSpace News Archive

Mydecine Innovations Group (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) (“Mydecine” or the “Company”), today announced that it has successfully synthesized a novel psilocin analogue with improved pharmaceutical properties to further expand its library of patent-pending tryptamines.

InflaRx N.V. announces positive data from the third cohort of patients in the Phase IIa open-label study with vilobelimab in Pyoderma Gangraenosum (PG).

Otonomy, Inc. today announced multiple presentations at the upcoming Neuroscience 2021 meeting

Cardurion Pharmaceuticals Announces Investment of up to $300 Million From Bain Capital

Frequency Therapeutics Virtual R&D Event to Detail FX-322 Clinical Advances, a New Program for Hearing Restoration and In Vivo Data from its MS Remyelination Program

TRACON Pharmaceuticals announced today that it will report its third quarter 2021 financial and operating results after the close of U.S. financial markets on Wednesday, November 3, 2021.

Galectin Pharmaceuticals to Present Six Scientific Abstracts at The Liver Meeting™ 2021, Hosted by the AASLD

Aetna®, a CVS Health® company (NYSE CVS), announced the launch of its designated Gene-based, Cellular, and Other Innovative Therapies™ (GCIT) network.

DiaCarta Inc.,today announced the publication of a study in PLOS ONE that demonstrates that DiaCarta’s ColoScape™ Xenonucleic Acid (XNA)-mediated quantitative real-time polymerase chain reactions (qPCR) clamping assay detects mutant cell-free DNA (cfDNA) from precancerous colorectal cancer (CRC) lesions and colorectal cancer.

New Members Add Deep Expertise in Translational and Clinical Drug Development, Corporate Strategy and Finance, Regulatory Affairs, and Investment